Skip to main content
For laboratory research use only. Not for human or veterinary use.
Free shipping on every order
10% off your first order · code FIRST10
BPC-157 + TB-500Preclinical

Thymosin beta 4 improves dermal burn wound healing via downregulation of receptor of advanced glycation end products in db/db mice

Xu TJ, Wang Q, Ma XW, et al. · Biochim Biophys Acta · 2014
PMID: 25230158 · DOI: 10.1016/j.bbagen.2014.09.005
Summary

db/db diabetic mouse burn wound model characterizing thymosin beta 4 effects with mechanistic readout of RAGE expression. Endpoints: histologic healing, RAGE/inflammation markers across the healing time course.

Read the full citation on PubMed

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

Compounds referenced in this study
  • TB-500 (Long Chain)
    Synthetic acetylated thymosin-β4 (1-43) analog. Studied in tissue-regeneration research.
    View product →
Guides covering this compound
More BPC-157 + TB-500 citations
Browse the catalog